[1] Lusis AJ. Atherosclerosis[J]. Nature, 2000, 407(6801): 233-41. [2] Yen GC, Chen HY. Scavenging effect of various tea extracts on su peroxide derived from the metabolism of mutagens [J]. Biosci Biotechnol Biochem, 1998, 62(9): 1768-70. [3] Ahn HY, Hadizadech KR, Seul C, et al. Epigallocathechin-3-gallate selectively inhibits the PDGF-BB induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH3T3 fibroblasts and human glioblastoma cells(A172) [J]. Mol Biol Cell, 1999, 10(4): 1093-04. [4] Kasper M, Funk RHW. Age-related changes in cells and tissues due to advanced glycation end products [J]. Arch Gerontol Geriatr, 2001, 32(3): 233-43. [5] Elion EA. Routing MAP kinase cascades [J]. Science, 1998, 11 (5383):1625-6. [6] Minden A, Karin M, Regulation and function of the JNK subgroup of MAP kinases[J]. Biochim Biophys Acta, 1997, 1333(2): F85- 104. [7] Mikkola I, Bruun JA, Bjorkoy G, et al. Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated ki nase and p44/42 mitogen-activated protein kinase[J]. J Biol Chem, 1999, 274(21): 15115-26. [8] Bennett AM,Tonks NK. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases[J]. Science, 1997, 278(5341): 1288-91. [9] Kim S, Izumi Y, Yano M, et al. Angiotensin blockade inhibits acti vation of mitogen-activated protein kinases in rat balloon-injured artery[J]. Circulation, 1998, 97(17): 1731-7. [10] Agarwal R, Katiyar SK, Zaidi SIA, et al. Inhibition of skin tumor promoter-caused induction of epidermal omothine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives [J]. Cancer Res, 1992, 52 (13): 3582-8. [11] Hou FF, Chertow GM, Kay J. Interaction between beta 2-microglob ulin and advanced glycation end products in the development of dialysis related-amyloidosis [J]. Kidney Int, 1997, 51 (5): 1514-9. [12] Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the devel opment of atherosclerosis in apoprotein E-deficient mice [J]. J Nutr, 2001, 131(1): 27-32. [13] Tijburg LB, Mattem T, Folts JD, et al. Tea flavonoids and cardio vascular disease[J]. Crit Rev Food Sci Nutr, 1997, 37(8): 771-85. [14] Arts IC, Hollman PC, Feskens EJ, et al. Catechin intake might ex plain the inverse relation between tea consumption and isehemic heart disease: the Zutphen Elderly Study[J]. Am J Clin Nutr, 2001,74(2): 227-32. [15] Bogoyevitch MA. Singnalling via strss-activated mitogen-activated protein kinases in the cardiovascular system [J]. Cardiovasc Res, 2000,45(4): 826-42. [16] King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications[J]. Endocrinol Metab Clin North Am, 1996, 25(2): 255-70. [17] Kume S, Takeya M, Mori T, et al. Immunohistochemical and ultra structural detection of advanced glycation end products in atheroscle rotic lesions of human aorta using a novel specific monoclonal anti body[J]. Am J Pathol, 1995, 147(3): 654-67. [18] Sano H, Nagai R, Matsumoto K, et al. Receptors for proteins modi fied by advanced glycation end products (AGE) - their functional role in atherosclerosis[J]. Mech Aging Dev, 1999, 107(3): 333-46. [19] Schmidt AM, Yan SD, Wautier JL, et al. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis[J]. Circ Res, 1999, 84(5): 489-97. [20] Huang JS, Guh JY, Chen HC, et al. Role of receptor for advanced glycation end products (RAGE) and the JAK/STAT-signaling path way in AGE-induced collagen production in NRK-49F cells [J]. J Cell Biochem, 2001, 81(1): 102-13. [21] Satoh H, Togo M, Hara M, et al. Advanced glycation end products stimulate mitogen-activated protein kinase and proliferation in rab bit vascular smooth muscle cells [J]. Biochem Biophys Res Com mun, 1997, 239(1): 111-5. [22] Schmidt AM, Yan SD, Yan SF, et al. The biology of the receptor for advanced glycation end products and its ligands [J]. Biochem Bio phys Acta, 2000, 1498(2-3): 99-111. |